Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.18 USD | +6.09% | +3.46% | -5.59% |
12:51pm | Leerink Adjusts Price Target on Pfizer to $29 From $27 | MT |
12:45pm | BMO Capital Adjusts Pfizer's Price Target to $36 From $33, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.59% | 154B | |
+33.25% | 699B | |
+25.40% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.83% | 236B | |
+4.91% | 198B | |
-10.10% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Pfizer : Astellas Receive Positive Opinion From European Medicines Agency for Xtandi